Research Paper Volume 16, Issue 2 pp 1696—1711

Therapeutic strategies and predictive models for Xp11.2 translocation/TFE3 gene fusion renal cell carcinoma in adults based on data of two Chinese medical centers


Figure 6. Contrast-enhanced computed tomography results of postoperative follow-up in a patient with TFE3-RCC. (A) The results of re-examination one month after the surgery; (B) three months after surgery, the patient’s re-examination showed multiple tumor metastases in the abdominal wall, left psoas major muscle, and pelvic cavity, so the patient started sunitinib therapy; (C) the re-examination results at six months after surgery showed that the metastasis was smaller than before, and the disease progression was controlled.